1262P - Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)
| Autor: | Faehling, M., Achenbach, J., Staib, P., Steffen, U., Tessen, H.W., Brugger, W. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi437-vi437 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|